Bruker (BRKR) Secures New Orders for High-Performance NMR Instruments Across Top U.S. Research Centers

Bruker Corporation (NASDAQ:BRKR) ranks among the best medical device stocks to invest in. Bruker Corporation (NASDAQ:BRKR) reported on October 3 that it had received new orders for advanced Nuclear Magnetic Resonance (NMR) instruments from three major US research organizations. The orders, valued at nearly $10 million, were from the New York Structural Biology Center (NYSBC), the University of Delaware, and Northwestern University.

NYSBC has placed an order for the first Multifield NMR Relaxometry System in North America. In contrast, NSF funding has been used to acquire a 600 MHz Dynamic Nuclear Polarization NMR spectrometer for the Department of Chemistry and Biochemistry at the University of Delaware.

Meanwhile, Northwestern University’s Integrated Molecular Structure Education and Research Center has placed an order for an 800 MHz NMR spectrometer, which will assist more than 15 NIH-funded research groups and the broader Chicago research community.

Bruker Corporation (NASDAQ:BRKR), a leading American manufacturer of high-performance scientific equipment, focuses on tools for molecular and materials research, as well as industrial analysis.

While we acknowledge the potential of BRKR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BRKR and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.